✉news WorldUS Politics first seen 7 d ago, last 7 d ago, peak #20
Inside the 340B Rebate Pilot Standoff
Original: Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
A standoff is unfolding over a 340B rebate pilot program, with drugmakers, federal courts, and Congress all playing roles in the dispute. The 340B program requires drug manufacturers to provide discounted medications to certain healthcare providers, and efforts to restructure discounts as rebates have triggered legal and legislative clashes over authority and implementation.
Why now: Ongoing litigation and congressional activity over the 340B rebate pilot are drawing attention from healthcare and pharmaceutical industry watchers.
340B programdrugmakersUS CongressUS courts
Rank over time, top of the chart is #1. 9 snapshots from 7 d ago to 7 d ago.
Evidence
- Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers · Pharmaceutical Commerce
API: https://socialmediatrends-api.osmike.com/v1/trends/3272939